Business Description
Impact BioMedical Inc
NAICS : 541714
SIC : 2833
ISIN : US45259L2051
Description
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The Company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.33 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | 2.55 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | -12.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.71 | |||||
| 9-Day RSI | 43.6 | |||||
| 14-Day RSI | 44.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.79 | |||||
| Quick Ratio | 2.79 | |||||
| Cash Ratio | 2.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -2.42 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | 4.44 | |||||
| ROA % | 2.58 | |||||
| ROIC % | -6.77 | |||||
| ROC (Joel Greenblatt) % | 707.43 | |||||
| ROCE % | 5.94 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Owner-Earnings | 44.44 | |||||
| PB Ratio | 0.59 | |||||
| EV-to-EBIT | 13.28 | |||||
| EV-to-EBITDA | 8.54 | |||||
| EV-to-FCF | -8.66 | |||||
| Earnings Yield (Greenblatt) % | 7.53 | |||||
| FCF Yield % | -16.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:IBO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Impact BioMedical Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.208 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 44.05 | ||
| 14-Day ATR ($) | 0.344291 | ||
| 20-Day SMA ($) | 1.66647 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 1.16 - 3.25 | ||
| Shares Outstanding (Mil) | 11.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Impact BioMedical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Impact BioMedical Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Impact BioMedical Inc Frequently Asked Questions
What is Impact BioMedical Inc(IBO)'s stock price today?
The current price of IBO is $1.60. The 52 week high of IBO is $3.25 and 52 week low is $1.16.
When is next earnings date of Impact BioMedical Inc(IBO)?
The next earnings date of Impact BioMedical Inc(IBO) is 2025-02-28 Est..
Does Impact BioMedical Inc(IBO) pay dividends? If so, how much?
Impact BioMedical Inc(IBO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers